Quarter 2026/Q2
| Line item | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 |
|---|---|---|---|---|---|
| Total Assets | $1.08B | $1.24B | $1.09B | $1.17B | $1.14B |
| Total Current Assets | $669.97M | $824.29M | $673.50M | $762.51M | $737.94M |
| Cash and Cash Equivalents & Short-Term Investments | $242.26M | $340.97M | $271.50M | $316.02M | $304.73M |
| -Cash and Cash Equivalents | $242.26M | $340.97M | $271.50M | $265.34M | $258.37M |
| Receivables | $407.96M | $459.30M | $377.71M | $417.68M | $416.95M |
| -Accounts Receivable | $216.09M | $268.87M | $197.23M | $218.95M | $209.88M |
| -Other Receivables | $191.87M | $190.43M | $180.49M | $198.73M | $207.07M |
| Other Current Assets | $19.75M | $24.02M | $24.30M | $28.81M | $16.25M |
| Total Non-Current Assets | $409.39M | $411.09M | $412.11M | $403.99M | $400.34M |
| Net PPE | $14.36M | $13.65M | $12.85M | $11.74M | $10.14M |
| -Gross PPE | $22.21M | $20.96M | $19.44M | $17.85M | $15.94M |
| -Accumulated Depreciation | -$7.86M | -$7.30M | -$6.59M | -$6.11M | -$5.80M |
| Goodwill and Other Intangible Assets | $345.60M | $346.18M | $346.71M | $346.56M | $345.53M |
| -Goodwill | $182.88M | $183.05M | $183.73M | $183.75M | $183.68M |
| -Other Intangible Assets | $162.73M | $163.13M | $162.99M | $162.81M | $161.85M |
| Other Non-Current Assets | $49.43M | $51.26M | $52.54M | $45.69M | $44.67M |
| Total Liabilities | $689.47M | $804.46M | $655.93M | $732.05M | $689.49M |
| Total Current Liabilities | $441.62M | $560.35M | $420.85M | $471.69M | $462.66M |
| Payables | $410.11M | $526.63M | $390.83M | $439.01M | $430.65M |
| -Accounts Payable | $410.11M | $526.63M | $390.83M | $439.01M | $430.65M |
| Current Accrued Expenses | $31.51M | $33.72M | $30.02M | $32.68M | $32.01M |
| Total Non-Current Liabilities | $247.85M | $244.10M | $235.08M | $260.36M | $226.83M |
| Long Term Debt and Capital Lease Obligation | $205.00M | $200.00M | $190.00M | $220.00M | $186.50M |
| -Long Term Debt | $205.00M | $200.00M | $190.00M | $220.00M | $186.50M |
| Other Non-Current Liabilities | $42.85M | $44.10M | $45.08M | $40.36M | $40.33M |
| Total Equity | $389.89M | $430.92M | $429.68M | $434.45M | $448.78M |
| Stockholders' Equity | $389.89M | $430.92M | $429.68M | $434.45M | $448.78M |
| Capital Stock | $169,000.00 | $174,000.00 | $173,000.00 | $172,000.00 | $172,000.00 |
| -Common Stock | $169,000.00 | $174,000.00 | $173,000.00 | $172,000.00 | $172,000.00 |
| -Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid-In Capital | $977.36M | $1.01B | $996.63M | $981.79M | $971.39M |
| Retained Earnings | -$587.58M | -$579.35M | -$568.46M | -$548.90M | -$524.43M |
| Gains/Losses Not Affecting Retained Earnings | -$63,000.00 | $258,000.00 | $1.34M | $1.38M | $1.65M |
| -Short Term Investments | – | – | $0.00 | $50.68M | $46.37M |
| Line item | 2025 ANNUAL | 2024 ANNUAL | 2023 ANNUAL | 2022 ANNUAL | 2021 ANNUAL |
|---|---|---|---|---|---|
| Operating Cash Flow | $78.23M | $65.40M | -$17.89M | -$75.18M | $85.29M |
| Net cash flow from continuing operations | $78.23M | $65.40M | -$17.89M | -$75.18M | $85.29M |
| Net Income from Continuing Operations | -$66.14M | -$79.70M | -$75.26M | -$102.19M | -$78.18M |
| Depreciation & Depletion & Amortization | $43.74M | $36.81M | $19.29M | $11.38M | $8.75M |
| Other Non-Cash Items | $3.54M | $741,000.00 | -$1.46M | -$57,000.00 | $656,000.00 |
| Change in Working Capital | $6.18M | $29.55M | -$21.02M | -$34.68M | $125.88M |
| -Change in Receivables | -$31.02M | $17.47M | $14.41M | $47.17M | -$120.16M |
| -Change in Payables and Accrued Expense | $46.82M | $16.17M | -$34.61M | -$73.09M | $242.86M |
| -Change in Other Current Assets | -$10.54M | -$424,000.00 | -$310,000.00 | -$1.35M | -$2.66M |
| -Change in Other Current Liabilities | $916,000.00 | -$3.66M | -$500,000.00 | -$7.40M | $5.84M |
| Net cash flow from investing | -$74.05M | -$15.86M | -$110.97M | -$282.98M | -$129.27M |
| Net Cash Flow from Continuing Investing Activities | -$74.05M | -$15.86M | -$110.97M | -$282.98M | -$129.27M |
| Capital Expenditure | -$35.56M | -$29.70M | -$25.84M | -$20.19M | -$11.46M |
| Net PPE Purchase and Sale | -$9.10M | -$4.54M | -$2.33M | -$3.21M | -$2.57M |
| Net Business Purchase and Sale | $0.00 | -$156.48M | -$29.62M | -$18.91M | -$64.50M |
| Net Investment Purchase and Sale | $46.40M | $182.78M | -$7.91M | -$202.69M | -$13.78M |
| Net Other Investing Changes | -$75.80M | -$22.01M | -$45.27M | -$37.98M | -$36.96M |
| Financing Cash Flow | $42.97M | -$7.87M | $30.63M | $72.93M | $376.25M |
| Net Cash Flow from Continuing Financing Activities | $42.97M | -$7.87M | $30.63M | $72.93M | $376.25M |
| Net Issuance Payments Of Debt | $67.00M | $8.00M | $39.50M | $75.00M | -$6.97M |
| Proceeds from Stock Option Exercised | $6.11M | $13.35M | $7.33M | $3.39M | $1.63M |
| Net Other Financing Charges | -$30.13M | -$29.22M | -$16.19M | -$5.46M | -$4.15M |
| Ending Cash Balance | $271.50M | $224.07M | $182.57M | $280.75M | $565.99M |
| Net Change in Cash | $47.16M | $41.66M | -$98.22M | -$285.22M | $332.27M |
| Beginning Cash Balance | $224.07M | $182.57M | $280.75M | $565.99M | $233.73M |
| Effect of Exchange Rate Changes | $277,000.00 | -$166,000.00 | $43,000.00 | -$21,000.00 | $0.00 |
| Free Cash Flow | $33.58M | $31.16M | -$46.06M | -$98.57M | $71.26M |
| Net Common Stock Issuance | – | – | – | – | $385.74M |
No comments yet — be the first to weigh in on ACVA.